Mar 23, 2026
Geneva/Labège, 23 March 2026. The French biotech company Antabio and the GARDP Foundation (known as GARDP) today announced a joint effort to accelerate crucial early-stage antibiotic discovery, responding to a steep rise in drug-resistant infections...
Sep 3, 2024
Labège, France, September 3rd, 2024. Antabio, a private biopharmaceutical company developing novel and highly differentiated antibacterial treatments for critical priority pathogens, with a particular focus on life-threatening respiratory infections, today announced...
Mar 19, 2024
Labège, France, March 19th 2024. Antabio SAS, a clinical stage biopharmaceutical company developing novel treatments for severe drug-resistantbacterial infections, is pleased to announce the appointment of Dr. Erick Lelouche as Chairman of the Board of Directors....
